Results 91 to 100 of about 15,167 (190)
, 1984 We evaluated the acute hemodynamic responses to hydralazine during cardiac catheterization in eight infants (ages 1.0 to 5.5 months) with congestive heart failure due to complete atrioventricular canal defect.
R J Boucek +4 more
core +1 more source
, 2014 Aim: Hydralazine, a vasodilator used in resistant hypertension (RH) treatment is metabolized by an acetylation reaction mediated by N-acetyltransferase 2, the activity of which depends on NAT2 polymorphisms.
Santos, Adalberto Rezende +4 more
core +1 more source
Haptenization as the missing link between vasculitis and myeloperoxidase
The Journal of Clinical InvestigationA wide variety of medications can induce adverse immune events and autoimmune responses such as vasculitis. Mechanistically, small molecule drugs known as haptens bind and modify endogenous proteins, triggering such immune reactions. In this issue of the
Laura Santambrogio
doaj +1 more source
In Vivo and In Vitro Effects of Hydralazine on Cellular Growth, Differentiation and Chromatin Structure [PDF]
, 1987 Hydralazine has been used medicinally as an antihypertensive since 1952. Within two years after its introduction to clinical medicine, an unusual set of symptoms was noted in a significant portion of patients.
Fasbender, Allen John
core +1 more source
Hydralazine-Induced ANCA Vasculitis Presenting With Pericarditis: A Novel Case and Literature Review
Case Reports in CardiologyHydralazine, a commonly used arterial vasodilator for managing congestive heart failure and hypertension, is known to be associated with drug-induced lupus and, less frequently, antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). Drug-
Ahmed Sami Hammami +7 more
doaj +1 more source
, 2013 Background and Objectives: Severe preeclampsia and eclampsia are responsible for 25% of maternal mortality, especially in developing countries. Considering the importance of this complication, the present study aimed to compare between effects of ...
Oghbaee N. +3 more
core
Effects of DNMT inhibitor hydralazine on LPS-induced rhabdomyolysis rats.
, 2016 Effects of DNMT inhibitor hydralazine on LPS-induced rhabdomyolysis rats.
Chih-Chin Shih (283129) +6 more
core +1 more source
Diagnosis and Treatment of Eclampsia
Journal of Cardiovascular Development and DiseaseHypertensive disorders of pregnancy affect approximately 5% to 10% of pregnant women. Eclampsia is a serious hypertensive disorder that is primarily characterized by the onset of grand mal seizure activity in the absence of other causative conditions ...
Vasiliki Katsi +3 more
doaj +1 more source
Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.
, 1982 To evaluate the effects of acute afterload reduction, hydralazine, 0.2 mg/kg, was administered at cardiac catheterization to seven infants who had a large ventricular septal defect (VSD). The infants were 2.5 - 11 months old (mean 5.1 months). Before and
R H Beekman, A P Rocchini, A Rosenthal
core +1 more source